If that is accurate -- and it may well be -- then it's over.
The present value of free cash flow off this indication is $0. Projected revenue - normal expenses - executive pigs at the trough = $0.
I will say this though. If the thesis on the MOA of EPA is really true, then CVD efficacy can't be all there is. It simply can't be. The impacts of systemic inflammation are legion.